应用搜索

Pfizer PAP India

com.onemg.patientportal
Medical 免费版 Everyone 在 Google Play 中打开
10,000+
次安装 · ≈14K
—
0 个评分
—
首次发布
2025-12-13
最近更新

说明

Patient Access Program enables access & affordability for Oncology drugs

Patient Access Program (PAP), being implemented by MediAngels (Tata 1mg Technologies Pvt. Ltd.), and supported by Pfizer India Limited is a PAN India Program for Oncology drugs providing better access and facilitating either a partial or full subsidy on these drugs. Currently there are 8 different PAPs available for oncology drugs (Dacoplice, Lorbriqua, Inonza, Palbace, Crizalk, Sutent, Inlyta, Aromasin and Campto). Each of these PAPs have various schemes available and depending upon the eligibility (as defined based on the indication for specific drugs) within the Program, patients may enroll themselves and avail the benefits of partial / full subsidy. Patients are prescribed these drugs by HealthCare Practitioners (HCPs) based on their medical conditions and post that patients may choose to enroll into the PAP. Once the patients consent to enroll, the MediAngels team facilitates the enrollment process by requesting for basic information & documents including photo ID proof, address proof and prescription. Enrollment into the Program is governed by patient’s eligibility as per the indication(s) defined for the specific drug. Upon successful completion of enrollment, patients may select PAP scheme from the available options and submit invoices (paid purchase proofs) along with valid prescriptions to avail free drug assistance.

新功能

We update our app regularly so that we can make it better for you. This release includes: - Bug fixes and improvements.

详情

版本3.2.0
最低 Android 版本7.0
评论数0
可用国家印度
开发者联系方式包含在 Business 套餐中
数据采集于2026-11-15

API 中的这些数据

完整的 JSON 应用详情消耗 1 个令牌。

curl -H "X-API-Key: YOUR_KEY" \
  "https://apkapi.com/api/v1/app?id=com.onemg.patientportal"